A randomized controlled trial of combined ivermectin and zinc sulfate versus combined hydroxychloroquine, darunavir/ritonavir, and zinc sulfate among adult patients with asymptomatic or mild coronavirus-19 infection-Reference-Cited by-同舟云学术

A randomized controlled trial of combined ivermectin and zinc sulfate versus combined hydroxychloroquine, darunavir/ritonavir, and zinc sulfate among adult patients with asymptomatic or mild coronavirus-19 infection

Published:2022 Issue:2 Volume:14 Page:69
ISSN:0974-777X
Container-title:Journal of Global Infectious Diseases
language:en
Short-container-title:J Global Infect Dis

Author:

Suputtamongkol Yupin,Nimitvilai Sireethorn,Poolvivatchaikarn Ussanee,Rassamekulthana Dechatorn,Rongkiettechakorn Nuttawut,Mungaomklang Anek,Assanasaen Susan,Wongsawat Ekkarat,Boonarkart Chompunuch,Sawaengdee Waritta

Publisher

Medknow

Subject

Infectious Diseases

Reference26 articles.

1. SARS-CoV-2 viral load in upper respiratory specimens of infected patients;Zou;N Engl J Med,2020

2. Duration of culturable SARS-CoV-2 within different specimens among mild and severe COVID-19 patients: A longitudinal study;Baek;J Infect,2021

3. The FDA-approved drug ivermectin inhibits the replication of SARS-CoV-2 in vitro;Caly;Antiviral Res,2020

4. Ivermectin as a potential COVID-19 treatment from the pharmacokinetic point of view: Antiviral levels are not likely attainable with known dosing regimens;Momekov;Biotechnol Biotechnol Equip,2020

5. Meta-analysis of randomized trials of ivermectin to treat SARS-CoV-2 infection;Hill;Open Forum Infect Dis,2021

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. An Update on SARS-CoV-2 Clinical Trial Results—What We Can Learn for the Next Pandemic;International Journal of Molecular Sciences;2023-12-26